Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Non-small Cell Lung Cancer × aumolertinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Non-small Cell Lung Cancer Metastatic 1 NSCLC 1 Brain Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 1 aumolertinib 1 anlotinib 1 abivertinib 1 Radiosurgery 1 Pemetrexed 1 Gefitinib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06043973 2023-09-21

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

Qianfoshan Hospital

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡